AptarGroup, Inc. (ATR)

NYSE: ATR · Real-Time Price · USD
143.71
+1.92 (1.35%)
Feb 27, 2026, 4:00 PM EST - Market closed
1.35%
Market Cap 9.25B
Revenue (ttm) 3.78B
Net Income (ttm) 392.79M
Shares Out 64.38M
EPS (ttm) 5.89
PE Ratio 24.40
Forward PE 25.92
Dividend $1.92 (1.35%)
Ex-Dividend Date Feb 4, 2026
Volume 344,625
Open 141.53
Previous Close 141.79
Day's Range 141.00 - 144.01
52-Week Range 103.23 - 164.28
Beta 0.49
Analysts Buy
Price Target 167.50 (+16.55%)
Earnings Date Feb 5, 2026

About ATR

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations,... [Read more]

Sector Healthcare
IPO Date Apr 21, 1993
Employees 14,000
Stock Exchange NYSE
Ticker Symbol ATR
Full Company Profile

Financial Performance

In 2025, AptarGroup's revenue was $3.78 billion, an increase of 5.42% compared to the previous year's $3.58 billion. Earnings were $392.79 million, an increase of 4.87%.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for ATR stock is "Buy." The 12-month stock price target is $167.5, which is an increase of 16.55% from the latest price.

Price Target
$167.5
(16.55% upside)
Analyst Consensus: Buy
Stock Forecasts

News

AptarGroup, Inc. (ATR) Presents at Bank of America 2026 Global Agriculture and Materials Conference Transcript

AptarGroup, Inc. (ATR) Presents at Bank of America 2026 Global Agriculture and Materials Conference Transcript

3 days ago - Seeking Alpha

Top 3 Materials Stocks That May Plunge This Month

As of Feb. 23, 2026, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Other symbols: KOPSCL
5 days ago - Benzinga

Aptar to Participate in Upcoming Investor Conferences

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Participate in Upcoming Investor Conferences.

9 days ago - Business Wire

AptarGroup, Inc. (ATR) Q4 2025 Earnings Call Transcript

AptarGroup, Inc. (ATR) Q4 2025 Earnings Call Transcript

21 days ago - Seeking Alpha

Aptar Reports Fourth Quarter and Annual 2025 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Fourth Quarter and Annual 2025 Results.

22 days ago - Business Wire

Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details.

5 weeks ago - Business Wire

Aptar Again Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Again Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment.

5 weeks ago - Business Wire

AptarGroup, Inc. (ATR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

AptarGroup, Inc. (ATR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

6 weeks ago - Seeking Alpha

Aptar Announces 2026 Quarterly Conference Call Dates

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces 2026 Quarterly Conference Call Dates.

7 weeks ago - Business Wire

Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.

7 weeks ago - Business Wire

Aptar's Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Group, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Bidose (BDS) L...

2 months ago - Business Wire

Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year.

3 months ago - Business Wire

Aptar Strengthens Latin America Footprint With Sommaplast Buy

On Monday, AptarGroup, Inc. (NYSE: ATR) acquired Sommaplast, a specialized provider of oral dosing pharma packaging solutions, such as closures, droppers, dispensers, and dosing cups, based in Brazil.

3 months ago - Benzinga

Touchstone Mid Cap Fund Q3 2025 Portfolio Review

The Touchstone Mid Cap Fund (Class A Shares, Load Waived) underperformed its benchmark, the Russell MidCap® Index, for the quarter ended September 30, 2025. Among the largest contributors to Fund perf...

3 months ago - Seeking Alpha

AptarGroup, Inc. (ATR) Presents at Jefferies London Healthcare Conference 2025 Transcript

AptarGroup, Inc. ( ATR) Jefferies London Healthcare Conference 2025 November 19, 2025 7:00 AM EST Company Participants Stephan Tanda - President, CEO & Executive Director Gael Touya - President of Ap...

3 months ago - Seeking Alpha

Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025.

3 months ago - Business Wire

AptarGroup: Pharma Setback Creates Long-Term Opportunities

AptarGroup's shares have dropped over 25% from summer highs due to slower growth, especially in high-margin pharma emergency solutions. ATR's valuation has compressed from 26x to 20x earnings, reflect...

4 months ago - Seeking Alpha

AptarGroup, Inc. (ATR) Q3 2025 Earnings Call Transcript

AptarGroup, Inc. ( ATR) Q3 2025 Earnings Call October 31, 2025 9:00 AM EDT Company Participants Marry Skafidas - Senior Vice President of Investor Relations & Communications Stephan Tanda - President...

4 months ago - Seeking Alpha

Aptar Reports Third Quarter 2025 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Third Quarter 2025 Results.

4 months ago - Business Wire

The London Company Mid Cap Portfolio: Top 3 Contributors And Detractors

The London Company Mid Cap portfolio increased 1.5% gross (1.3% net) during the quarter vs. a 5.3% increase in the Russell Midcap Index. Both stock selection & sector exposure were headwinds to relati...

Other symbols: ALSNAWIFISNEUSGI
4 months ago - Seeking Alpha

AptarGroup, Inc. (ATR) 2025 Investor Day Call (Transcript)

AptarGroup, Inc. (NYSE:ATR) 2025 Investor Day Call Company Participants Marry Skafidas - Senior Vice President of Investor Relations & Communications Stephan Tanda - President, CEO & Executive Direct...

6 months ago - Seeking Alpha

Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength.

6 months ago - Business Wire

Aptar Announces 2025 Investor Day

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces 2025 Investor Day.

6 months ago - Business Wire

AptarGroup, Inc. (ATR) Q2 2025 Earnings Call Transcript

AptarGroup, Inc. (NYSE:ATR) Q2 2025 Earnings Conference Call August 1, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President of Investor Relations & Communications Stephan B. Tan...

7 months ago - Seeking Alpha

Aptar Reports Second Quarter 2025 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Second Quarter 2025 Results.

7 months ago - Business Wire